ALSTON PHARMACY LIMITED
Opportunity 77/100 (strong), bankability 80/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Discharge stale live charges. 1 live charge(s) created 15+ years ago — likely paid but undischarged. Clean register. Most likely exit: strategic trade sale (65/100).
Refinance opportunity
1 live charge · oldest 15.2y
Refinance would be pressure-driven, not opportunity-driven. Expect tighter margins and covenant scrutiny.
- · Oldest live charge is 15.2 years old — likely at or near maturity.
- · Single lender — cleanest path to refinance.
- · Distress signals active — lender appetite narrows.
Data confidence
Overall: medium (77/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Key financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · accounting standard unknown| Metric | 2025-03-31 | 2024-03-31 |
|---|---|---|
| Total assets | — | £39.7k |
| Current assets | — | £97.5k |
| Net assets | — | £26.2k |
| Average employees | 3 | — |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 1 persons-with-significant-control
- • 1 persons-with-significant-control
Corporate timeline (22 events)Click to expand
- 2026-03-25📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2025-11-20📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2024-12-09📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2023-11-24📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2022-12-22📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2021-12-20📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2021-03-31📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2019-11-15📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2018-12-23📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2017-12-22📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2017-09-14📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2017-09-14📄cessation-of-a-person-with-significant-controlpersons-with-significant-control · PSC07
- 2017-03-03📄resolutionresolution · RESOLUTIONS
- 2017-01-11📄change-person-director-company-with-change-dateofficers · CH01
- 2016-12-23📄accounts-with-accounts-type-total-exemption-smallaccounts · AA
- 2012-03-23➖CHAMBERS, Mary resignedsecretary
- 2012-03-23➖CHAMBERS, Mary resigneddirector
- 2011-03-15🔒Charge registered #1Lender: Santander UK PLC (Santander)
- 2010-09-01🏢Company incorporatedAs ALSTON PHARMACY LIMITED
- 2010-09-01➕MAGUIRE, Conor appointeddirector
- 2010-09-01➕CHAMBERS, Mary appointedsecretary
- 2010-09-01➕CHAMBERS, Mary appointeddirector
Owner dependency
The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.
- +Sole director: Only one active director — all governance concentrated on one person.
- +Long-tenure founder: Senior director has been in place 16 years — deep operational knowledge concentrated in one person.
Succession & seller-readiness
Multiple signals suggest succession is on the horizon. Candidate for proactive outreach.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
- secondary12+ year tenure: Director in role 16 years.
- secondaryStable-but-static management: Company is 16 years old and no new directors in the last 3 years — succession not yet being planned internally.
- supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.
Red flags
cleanShareholders & ownership
1 active beneficial owner · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Mr Conor Maguire Individual · British · DOB 12/1978 · age 48 | 75–100% | 75–100% | 75-100% shares · 75-100% voting | 06/04/2016 |
1 historic (ceased) PSC
- Philip James Chambersceased 13/12/2016· 25-50% shares · 25-50% voting
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Healthcare & medical · CA postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| 121 CARE AGENCY LIMITED→ 15657669 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| A&C STANLEY LTD→ 13002990 · est 2020 · no financials extracted | — | — | — | — | 5y | — | — |
| AB&DG SERVICES LIMITED→ 11603769 · est 2018 · no financials extracted | — | — | — | — | 7y | — | — |
| ABSHA LIMITED→ 14644931 · est 2023 · no financials extracted | — | — | — | — | 3y | — | — |
| ACTIVE MEDICAL LIMITED→ 04432916 · est 2002 · no financials extracted | — | — | — | — | 23y | — | — |
| ACTIVELIFE MEDIC-CARE UK LTD→ 14071631 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| ADSTAPHIMED LIMITED→ 14024628 · est 2022 · no financials extracted | — | — | — | — | 4y | — | — |
| ADVANCED AESTHETICS DR EWELINA EMILIANOWICZ LTD→ 15562826 · est 2024 · no financials extracted | — | — | — | — | 2y | — | — |
| ALL SEASONS HOME CARE (CARLISLE) LIMITED→ 07347506 · est 2010 · no financials extracted | — | — | — | — | 15y | — | — |
| AMIDENT LIMITED→ 14477432 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| AMIT PAIK LTD→ 13138624 · est 2021 · no financials extracted | — | — | — | — | 5y | — | — |
| AMS ST HELENS LIMITED→ 11761082 · est 2019 · no financials extracted | — | — | — | — | 7y | — | — |
7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (1 active · 2 resigned)
Click a director name to see their full track record across all companies.
Mortgages & charges
| Type | Properties | |||||
|---|---|---|---|---|---|---|
| outstanding | Santander Santander UK PLC (Santander) | Legal and general charge | 1 property | 15/03/2011 | — |